List of works - Vanessa Selak

Acknowledging and acting on racism in the health sector in Aotearoa New Zealand

scientific article published on 04 September 2020

Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet Therapy

scientific article published on 01 June 2018

Are ethnic inequalities in 30-day ischaemic stroke survival emerging as treatment becomes more effective?

scientific article published on July 2016

Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease?

scholarly article

Aspirin for primary prevention: yes or no?

scientific article published on June 2010

Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH Trial

scientific article published on 22 July 2020

Cardiovascular disease and its management among Pacific people: a systematic review by ethnicity and place of birth

scholarly article

Cardiovascular disease preventive medication dispensing for almost every New Zealander 65 years and over: a preventive treatment paradox?

scholarly article

Cardiovascular risk management of different ethnic groups with type 2 diabetes in primary care in New Zealand

scientific article

Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study

Cardiovascular treatment gaps: closing, but slowly.

scientific article published on 24 April 2009

Contrasting trends in heart failure incidence in younger and older New Zealanders, 2006–2018

Danazol for pelvic pain associated with endometriosis

scientific article

Decision-making in an era of cancer prevention via aspirin: New Zealand needs updated guidelines and risk calculators

scientific article published on 11 March 2016

Dispensing data captures individual-level use of aspirin for cardiovascular disease prevention, despite availability over-the-counter

scientific article

Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular disease

scientific article published on 4 March 2016

Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care

scientific article published on 27 May 2014

Effectiveness and safety of a cardiovascular polypill containing aspirin ⬇️

2015 doctoral thesis by Vanessa Selak at University of Auckland

Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries

scientific article

Ethnic differences in cardiovascular risk profiles among 475,241 adults in primary care in Aotearoa, New Zealand

scientific article published on 4 September 2020

Feasibility and reliability of clinical coding surveillance for the routine monitoring of adverse drug events in New Zealand hospitals

article

Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka

scientific article published in The Journal of the American Medical Association

Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial

scientific article published on 30 August 2019

Gaps in primary care documentation of cardiovascular risk factors.

scientific article

IMProving Adherence using Combination Therapy (IMPACT): design and protocol of a randomised controlled trial in primary care

scientific article published on 18 July 2011

Impact of switching to polypill based therapy by baseline potency of medication: Post-hoc analysis of the SPACE Collaboration dataset

scientific article

Indigenous health worker support for patients with poorly controlled type 2 diabetes: study protocol for a cluster randomised controlled trial of the Mana Tū programme

article

Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice

scientific article published on 1 April 2008

Is general practice identification of prior cardiovascular disease at the time of CVD risk assessment accurate and does it matter?

article by Sue Wells et al published 18 May 2018 in The New Zealand Medical Journal

Long-term follow up of older people on diabetes medications: observational study using linked health databases

scientific article published on 30 June 2020

Mana Tū: a whānau ora approach to type 2 diabetes

scholarly article

Manawataki Fatu Fatu for ACCESS (Māori and Pacific Hearts in Unison for Achieving Cardiovascular Care in Equity StudieS). Protocol for a Mixed Methods Programme of Research

Performance of CVD risk equations for older patients assessed in general practice: a cohort study

scientific article published on 26 June 2020

Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention: A Benefit-Harm Analysis

scientific article published on 17 September 2019

Polypill-based therapy likely to reduce ethnic inequities in use of cardiovascular preventive medications: Findings from a pragmatic randomised controlled trial

scientific article published on 29 February 2016

Polypills for the secondary prevention of cardiovascular disease: effective in improving adherence but are they safe?

scientific article published on 20 December 2017

Predicting Bleeding Risk to Guide Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Cohort Study

scientific article published on 26 February 2019

Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE Collaboration

scientific article published on 12 October 2013

Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials

scientific article published on 28 June 2018

Recruiting equal numbers of indigenous and non-indigenous participants to a 'polypill' randomized trial

scientific article published on 22 June 2013

Relationship between estimated glomerular filtration rate and incident cardiovascular disease in an ethnically diverse primary care cohort

scientific article published on 8 March 2019

Research Ideas Worth Funding III - Panel discussion

Smoking status recording in GP electronic records: the unrealised potential

scientific article published on 01 January 2006

TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol

scientific article published on 6 November 2013

The State of Quality Improvement Teaching in Medical Schools: A Systematic Review

scientific article published on 10 February 2020

The efficacy and tolerability of 'polypills': meta-analysis of randomised controlled trials

scientific article

The strong case for government funding of a polypill for the secondary prevention of cardiovascular disease in New Zealand

scientific article published on 20 September 2019

Therapeutics. Intensive blood pressure control did not prevent major CV events more than standard control in type 2 diabetes

scientific article published on 01 July 2010

Trends in cardiovascular outcomes after acute coronary syndrome in New Zealand 2006–2016

scientific article published on 21 August 2020

Understanding the barriers and facilitators that influence access to quality cardiovascular care for rural Indigenous peoples: protocol for a scoping review

What are the gaps in cardiovascular risk assessment and management in primary care for Māori and Pacific people in Aotearoa New Zealand? Protocol for a systematic review

scientific article published on 08 June 2022

What is the Optimal Rate of Invasive Coronary Angiography After Acute Coronary Syndrome? (ANZACS-QI 22)

scientific article published on 02 February 2019

Will a web-based cardiovascular disease (CVD) risk assessment programme increase the assessment of CVD risk factors for Maori?

scientific article published on 21 July 2006

List of works by Vanessa Selak

Acknowledging and acting on racism in the health sector in Aotearoa New Zealand

Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet Therapy

Are ethnic inequalities in 30-day ischaemic stroke survival emerging as treatment becomes more effective?

Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease?

Aspirin for primary prevention: yes or no?

Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH Trial

Cardiovascular disease and its management among Pacific people: a systematic review by ethnicity and place of birth

Cardiovascular disease preventive medication dispensing for almost every New Zealander 65 years and over: a preventive treatment paradox?

Cardiovascular risk management of different ethnic groups with type 2 diabetes in primary care in New Zealand

Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study

Cardiovascular treatment gaps: closing, but slowly.

Contrasting trends in heart failure incidence in younger and older New Zealanders, 2006–2018

Danazol for pelvic pain associated with endometriosis

Decision-making in an era of cancer prevention via aspirin: New Zealand needs updated guidelines and risk calculators

Dispensing data captures individual-level use of aspirin for cardiovascular disease prevention, despite availability over-the-counter

Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular disease

Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care

Effectiveness and safety of a cardiovascular polypill containing aspirin ⬇️

Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries

Ethnic differences in cardiovascular risk profiles among 475,241 adults in primary care in Aotearoa, New Zealand

Feasibility and reliability of clinical coding surveillance for the routine monitoring of adverse drug events in New Zealand hospitals

Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka

Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial

Gaps in primary care documentation of cardiovascular risk factors.

IMProving Adherence using Combination Therapy (IMPACT): design and protocol of a randomised controlled trial in primary care

Impact of switching to polypill based therapy by baseline potency of medication: Post-hoc analysis of the SPACE Collaboration dataset

Indigenous health worker support for patients with poorly controlled type 2 diabetes: study protocol for a cluster randomised controlled trial of the Mana Tū programme

Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice

Is general practice identification of prior cardiovascular disease at the time of CVD risk assessment accurate and does it matter?

Long-term follow up of older people on diabetes medications: observational study using linked health databases

Mana Tū: a whānau ora approach to type 2 diabetes

Manawataki Fatu Fatu for ACCESS (Māori and Pacific Hearts in Unison for Achieving Cardiovascular Care in Equity StudieS). Protocol for a Mixed Methods Programme of Research

Performance of CVD risk equations for older patients assessed in general practice: a cohort study

Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention: A Benefit-Harm Analysis

Polypill-based therapy likely to reduce ethnic inequities in use of cardiovascular preventive medications: Findings from a pragmatic randomised controlled trial

Polypills for the secondary prevention of cardiovascular disease: effective in improving adherence but are they safe?

Predicting Bleeding Risk to Guide Aspirin Use for the Primary Prevention of Cardiovascular Disease: A Cohort Study

Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE Collaboration

Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials

Recruiting equal numbers of indigenous and non-indigenous participants to a 'polypill' randomized trial

Relationship between estimated glomerular filtration rate and incident cardiovascular disease in an ethnically diverse primary care cohort

Research Ideas Worth Funding III - Panel discussion

Smoking status recording in GP electronic records: the unrealised potential

TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol

The State of Quality Improvement Teaching in Medical Schools: A Systematic Review

The efficacy and tolerability of 'polypills': meta-analysis of randomised controlled trials

The strong case for government funding of a polypill for the secondary prevention of cardiovascular disease in New Zealand

Therapeutics. Intensive blood pressure control did not prevent major CV events more than standard control in type 2 diabetes

Trends in cardiovascular outcomes after acute coronary syndrome in New Zealand 2006–2016

Understanding the barriers and facilitators that influence access to quality cardiovascular care for rural Indigenous peoples: protocol for a scoping review

What are the gaps in cardiovascular risk assessment and management in primary care for Māori and Pacific people in Aotearoa New Zealand? Protocol for a systematic review

What is the Optimal Rate of Invasive Coronary Angiography After Acute Coronary Syndrome? (ANZACS-QI 22)

Will a web-based cardiovascular disease (CVD) risk assessment programme increase the assessment of CVD risk factors for Maori?